Accolade, Inc. of Pennsylvania provides healthcare related information for self-insured companies. The Company assists employees and their families to make healthcare decisions through its health assistants. Accolade serves customers in the United States.

Company profile
Ticker
ACCD
Exchange
Website
CEO
Rajeev Singh
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Alibaba Group Holding • EBay • Visa • DiDi Global • Uber • PayPal • Accenture • Nielsen • Mastercard • Bread Financial ...
Former names
Accolade LLC
SEC CIK
Corporate docs
Subsidiaries
Accolade Techologies s.r.o. • MD Insider, Inc. • Accolade 2ndMD LLC • 1stMD LLC • PlushCare, Inc. • PlushCare Technologies Canada, Inc. ...
IRS number
432117836
ACCD stock data
Analyst ratings and price targets
Current price
Average target
$13.33
Low target
$11.00
High target
$15.00
Raymond James
Initiated
$15.00
Truist Securities
Maintains
$14.00
Morgan Stanley
Maintains
$11.00
Latest filings (excl ownership)
8-K
Accolade Announces Results for Fiscal Third Quarter 2023
9 Jan 23
10-Q
2023 Q3
Quarterly report
9 Jan 23
10-Q
2023 Q2
Quarterly report
6 Oct 22
8-K
Accolade Announces Results for Fiscal Second Quarter 2023
6 Oct 22
8-K
Submission of Matters to a Vote of Security Holders
27 Jul 22
8-K
Entry into a Material Definitive Agreement
21 Jul 22
10-Q
2023 Q1
Quarterly report
1 Jul 22
8-K
Accolade Announces Results for Fiscal First Quarter 2023
30 Jun 22
DEF 14A
Definitive proxy
24 Jun 22
S-8
Registration of securities for employees
3 Jun 22
Transcripts
ACCD
Earnings call transcript
2023 Q2
7 Oct 22
ACCD
Earnings call transcript
2023 Q1
1 Jul 22
ACCD
Earnings call transcript
2022 Q4
29 Apr 22
ACCD
Earnings call transcript
2022 Q3
11 Jan 22
ACCD
Earnings call transcript
2022 Q2
8 Oct 21
ACCD
Earnings call transcript
2022 Q1
9 Jul 21
ACCD
Earnings call transcript
2021 Q4
9 May 21
ACCD
Earnings call transcript
2021 Q3
7 Jan 21
ACCD
Earnings call transcript
2021 Q2
14 Oct 20
ACCD
Earnings call transcript
2021 Q1
13 Aug 20
Latest ownership filings
Financial summary
Quarter (USD) | Nov 22 | Aug 22 | May 22 | Feb 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Feb 22 | Feb 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 325.64 mm | 325.64 mm | 325.64 mm | 325.64 mm | 325.64 mm | 325.64 mm |
Cash burn (monthly) | 1.67 mm | 3.36 mm | 13.46 mm | 38.67 mm | 1.56 mm | 3.37 mm |
Cash used (since last report) | 3.83 mm | 7.74 mm | 30.98 mm | 88.99 mm | 3.60 mm | 7.75 mm |
Cash remaining | 321.80 mm | 317.90 mm | 294.66 mm | 236.64 mm | 322.04 mm | 317.88 mm |
Runway (months of cash) | 193.2 | 94.6 | 21.9 | 6.1 | 205.9 | 94.4 |
Institutional ownership, Q3 2022
81.2% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 148 |
Opened positions | 17 |
Closed positions | 25 |
Increased positions | 56 |
Reduced positions | 44 |
13F shares | Current |
---|---|
Total value | 632.20 mm |
Total shares | 59.13 mm |
Total puts | 300.70 k |
Total calls | 119.00 k |
Total put/call ratio | 2.5 |
Largest owners | Shares | Value |
---|---|---|
JPM JPMorgan Chase & Co. | 5.95 mm | $67.94 mm |
Brown Advisory | 5.94 mm | $67.86 mm |
ARK Investment Management | 5.92 mm | $67.59 mm |
BLK Blackrock | 4.84 mm | $55.30 mm |
Vanguard | 4.42 mm | $50.43 mm |
Andreessen Horowitz Fund IV | 3.78 mm | $0.00 |
AH Equity Partners IV | 3.78 mm | $43.16 mm |
BLVGF Bellevue | 3.57 mm | $40.79 mm |
Rock Springs Capital Management | 2.27 mm | $25.97 mm |
Millennium Management | 1.70 mm | $19.45 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Jan 23 | Singh Rajeev | Common Stock | Sell | Dispose S | No | No | 9.9634 | 276 | 2.75 k | 153,865 |
18 Jan 23 | Cavanaugh Robert N | Common Stock | Sell | Dispose S | No | No | 9.9634 | 176 | 1.75 k | 144,796 |
18 Jan 23 | Michael W Hilton | Common Stock | Sell | Dispose S | No | No | 9.9634 | 99 | 986.38 | 129,735 |
18 Jan 23 | Stephen H. Barnes | Common Stock | Sell | Dispose S | No | No | 9.9634 | 138 | 1.37 k | 123,237 |
17 Jan 23 | Singh Rajeev | Common Stock | Option exercise | Acquire M | No | No | 0 | 932 | 0.00 | 154,141 |
17 Jan 23 | Singh Rajeev | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 932 | 0.00 | 27,053 |
17 Jan 23 | Cavanaugh Robert N | Common Stock | Option exercise | Acquire M | No | No | 0 | 510 | 0.00 | 144,972 |
17 Jan 23 | Cavanaugh Robert N | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 510 | 0.00 | 14,790 |
17 Jan 23 | Michael W Hilton | Common Stock | Option exercise | Acquire M | No | No | 0 | 331 | 0.00 | 129,834 |
17 Jan 23 | Michael W Hilton | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 331 | 0.00 | 9,619 |
News
Analyst Initiates Coverage On Accolade, Says 'Differentiated In Growing Market'
2 Feb 23
Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2023
2 Feb 23
Raymond James Initiates Coverage On Accolade with Outperform Rating, Announces Price Target of $15
2 Feb 23
Truist Securities Maintains Buy on Accolade, Raises Price Target to $14
30 Jan 23
Analysts Stay Bullish On Accolade Stock, Call Q3 Earnings Better Than Expected Amid Challenging Backdrop
10 Jan 23
Press releases
Blue Shield of California Launches Virtual Blue Benefit Plan Incorporating Primary, Mental Health, and Specialty Care
30 Jan 23
Accolade Announces Results for Fiscal Third Quarter 2023
9 Jan 23
Accolade Champions Health Equity and Welcomes FOLX Health to Trusted Partner Ecosystem at HLTH 2022
14 Nov 22